Biomarin Pharmaceutical (BMRN) Q2 2026 Earnings

4MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.28
0.22
0.73
1.23

Details

Expected EPS
0.692105
Actual EPS
0.76
Surprise EPS
0.07
Surprise Percent
+9.81%

Description

Biomarin Pharmaceutical (BMRN) has reported earnings of 0.76 per share for Q2 2026.

0 Comments

Share your thoughts